Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001415889-14-001094
Filing Date
2014-04-04
Accepted
2014-04-03 19:02:26
Documents
18
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A cocrystal10ka_dec312013.htm 10-K/A 1403657
2 CERTIFICATE OF MERGER - DELAWARE ex2-4.htm EX-2.4 11068
3 CERTIFICATE OF MERGER - NEVADA ex2-5.htm EX-2.5 5416
4 CERTIFICATE OF INCORPORATION - DELAWARE ex3-7.htm EX-3.7 31353
5 BYLAWS ex3-9.htm EX-3.9 86263
6 FORM OF INDEMNIFICATION AGREEMENT ex10-13.htm EX-10.13 80386
7 SUBSIDIARIES ex21-1.htm EX-21.1 4138
8 PRINCIPAL ACCOUNTANT CONSENT ex23-1.htm EX-23.1 2397
9 ex31-1.htm EX-31.1 10885
10 ex31-2.htm EX-31.2 10800
11 ex32-1.htm EX-32.1 8627
12 cocrystales25page_1.jpg GRAPHIC 213893
13 cocrystales25page_2.jpg GRAPHIC 212777
14 cocrystales25page_3.jpg GRAPHIC 150556
15 cocrystales25page_4.jpg GRAPHIC 148222
16 cocrystales25page_5.jpg GRAPHIC 201595
17 cocrystales25page_6.jpg GRAPHIC 179911
18 cocrystal10k_dec3120130.jpg GRAPHIC 35557
  Complete submission text file 0001415889-14-001094.txt   3231324
Mailing Address 19805 NORTH CREEK PARKWAY BOTHELL WA 98011
Business Address 19805 NORTH CREEK PARKWAY BOTHELL WA 98011 (425) 398-7178
Cocrystal Pharma, Inc. (Filer) CIK: 0001412486 (see all company filings)

EIN.: 205978559 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-55158 | Film No.: 14743824
SIC: 2834 Pharmaceutical Preparations